Clinical trials
Terminated Depressive Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 1 |
| 2013 | 4 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 4 |
| GlaxoSmithKline | 2 |
| Limbix Health, Inc. | 2 |
| National Institute of Mental Health (NIMH) | 2 |
| University Hospital, Montpellier | 2 |
| University of Aarhus | 2 |
| VA Office of Research and Development | 2 |
| Abbott Medical Devices | 1 |
| Finnish Institute for Health and Welfare | 1 |
| Freeman-Sheldon Research Group, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Depressive Disorder | 45 |
| Major Depressive Disorder | 18 |
| Anxiety Disorders | 6 |
| Mood Disorders | 6 |
| Bipolar Disorder | 3 |
| Depressive Disorder, Treatment-Resistant | 3 |
| Mental Disorders | 2 |
| Stress Disorders, Post-Traumatic | 2 |
| Affective Disorders, Psychotic | 1 |
| Alcoholism | 1 |
Trials
Showing 51 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.